{{Rsnum
|rsid=1207421
|Gene=PARD3B
|Chromosome=2
|position=205285870
|Orientation=plus
|GMAF=0.1327
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=PARD3B
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 82.3 | 17.7 | 0.0
| HCB | 52.6 | 41.6 | 5.8
| JPT | 53.1 | 39.8 | 7.1
| YRI | 85.7 | 14.3 | 0.0
| ASW | 78.9 | 21.1 | 0.0
| CHB | 52.6 | 41.6 | 5.8
| CHD | 41.3 | 48.6 | 10.1
| GIH | 92.1 | 6.9 | 1.0
| LWK | 86.4 | 13.6 | 0.0
| MEX | 91.4 | 8.6 | 0.0
| MKK | 92.9 | 7.1 | 0.0
| TSI | 80.4 | 18.6 | 1.0
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs1207421
|PubMedID=18471798
|Condition=Knee osteoarthritis
|Gene=PARD3B
|Risk Allele=
|pValue=6.00E-006
|OR=1.46
|95CI=1.24-1.73
|OA=1
}}

{{PharmGKB
|RSID=rs1207421
|Name_s=
|Gene_s=PARD3B
|Feature=
|Evidence=PubMed ID:18471798; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide Association Scan Identifies a Prostaglandin-Endoperoxide Synthase 2 Variant Involved in Risk of Knee Osteoarthritis (Initial Sample Size: 357 cases, 285 controls; Replication Sample Size: 1,177 cases, 2,372 controls). This variant is associated with Knee osteoarthritis.
|Drugs=
|Drug Classes=
|Diseases=Osteoarthritis, Knee
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356476
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1207421
|overall_frequency_n=113
|overall_frequency_d=128
|overall_frequency=0.882812
|n_genomes=54
|n_genomes_annotated=0
|n_haplomes=97
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}